This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.
Abstract
High expression of LLGL2 promotes proliferation and drug resistance in ER+ breast cancer.
- ©2019 American Association for Cancer Research.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't.
June 2019
Volume 9, Issue 6
Volume 9, Issue 6
LLGL2 Promotes Adaptation to Nutrient Stress in ER+ Breast Cancer
Jump to section
Advertisement